MedPath

A prospective randomised controlled trial in the treatment of anal fissures; Botulin-A Toxin versus Topical Diltiazem: BOTTOM-trial.

Recruiting
Conditions
Anal fissure (NLD: anale fissuur).
Registration Number
NL-OMON29443
Lead Sponsor
B.A. Twigt, E.A te Velde, L. Stoker, E. Kuck, A. Pronk
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
164
Inclusion Criteria

Chronic anal fissure, without previous therapy.

Exclusion Criteria

1. Allergy to botuline A toxine and Diltiazem;

2. Cardiovascular disease:

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Healing of fissure.
Secondary Outcome Measures
NameTimeMethod
Costs and adverse events.
© Copyright 2025. All Rights Reserved by MedPath